Population clinical pharmacology of children: modelling covariate effects.
about
Drug-induced renal damage in preterm neonates: state of the art and methods for early detectionDevelopmental pharmacokinetics in pediatric populationsEducational paper: do we need neonatal clinical pharmacologists?Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adultsPopulation pharmacokinetics of oral baclofen in pediatric patients with cerebral palsyTolerance and withdrawal from prolonged opioid use in critically ill children.Challenges in conducting clinical trials in children: approaches for improving performancePharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyPopulation pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.Population pharmacokinetics of tamsulosin hydrochloride in paediatric patients with neuropathic and non-neuropathic bladderCovariates of intravenous paracetamol pharmacokinetics in adultsPopulation-Based Pharmacokinetic Modeling of Vancomycin in Children with Renal InsufficiencyPopulation pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.Reversing the myths obstructing the determination of optimal age- and disease-based drug dosing in pediatricsDevelopment of a Pediatric Physiologically Based Pharmacokinetic Model for Sirolimus: Applying Principles of Growth and Maturation in Neonates and Infants.Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation.Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and children.Population pharmacokinetics of etomidate in neonates and infants with congenital heart disease.Pharmacokinetics of Morphine and Its Metabolites in Infants and Young Children After Congenital Heart SurgeryUse of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens.Designing a Pediatric Study for an Antimalarial Drug by Using Information from AdultsImproved vancomycin dosing in children using area under the curve exposure.Optimizing drug development of anti-cancer drugs in children using modelling and simulation.Population Pharmacokinetics of Oral Topotecan in Infants and Very Young Children with Brain Tumors Demonstrates a Role of ABCG2 rs4148157 on the Absorption Rate Constant.Developmental pharmacology: neonates are not just small adults...Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patientsPopulation pharmacokinetics of lopinavir predict suboptimal therapeutic concentrations in treatment-experienced human immunodeficiency virus-infected children.Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children.Bioavailability of inhaled fluticasone propionate via chambers/masks in young children.Population pharmacokinetics and optimal design of paediatric studies for famciclovir.Pediatric Dosing and Body Size in Biotherapeutics.Dosing in children.The role of population PK-PD modelling in paediatric clinical research.Covariate effects and population pharmacokinetics of lamivudine in HIV-infected children.Developmental pharmacology of tramadol during infancy: ontogeny, pharmacogenetics and elimination clearance.Propofol and children--what we know and what we do not know.Pharmacokinetics and pharmacodynamics of intravenous acetaminophen in neonates.Population pharmacokinetic analysis during the first 2 years of life: an overview.
P2860
Q26849339-25A08EB1-8A6B-4582-A51E-0B306C6B922AQ27002933-54854825-AB41-4A15-9072-1460CC96BF2FQ27009662-D093801D-9E38-412B-B474-83FB17527E9CQ28539049-F69040DE-20BA-47CC-9CFC-DF5D1F38625AQ30405534-F0EE3628-698A-444A-9EAA-CCED8A98BD46Q30428413-F1D30948-A9D2-4214-8771-52ECAE45ED02Q33717140-1E84F64B-6413-48CE-9113-22EAA2858374Q33826426-1875F6A1-F3A7-4F00-BDA1-AEDB719EF115Q33827819-3D8D983B-230D-46E4-A1C1-40287F811A87Q33888004-51520259-C2D6-43A8-8EB0-53FA0205AE30Q34019358-03E7D532-D97D-4027-A412-820C27780853Q34193839-51DD088D-A644-4146-83EC-650EBFB1577CQ34314798-A74336F9-36B8-4D16-880A-4AD9D0081D9FQ34570930-445D24C3-13DA-4734-B5CD-C89FCC95A0B0Q35104991-C129915D-A601-4848-8478-52C4E026C737Q35179536-52F58ED4-ECD3-4214-8533-B718F865739CQ36094883-57527F5F-FFDC-4D48-A600-D618E7E714ADQ36095091-1C4C29DD-456D-41B2-BBF4-05BFD7ED58F0Q36172421-E6D556DA-B147-4FDE-82F6-5363EA1D7AB5Q36239801-9EDF9834-EB65-469C-997A-9B3E7FF44B4BQ36445122-13334AB6-1943-4E9C-AC4B-D8A075E7CAD8Q36473125-BB85B361-66BB-4697-9B6B-1B0A323999FAQ36644652-EC885E75-015A-4E59-AC9A-12239BA38283Q36784672-FFB8FE44-42C7-4A72-85B2-701E6CE0E036Q36987975-10061C67-B71C-4405-92CB-9F4614354207Q37062610-7522343A-BCF3-449A-BC62-91F35E5106FEQ37127683-142FCB21-C3D8-49B9-9EF9-086E9C0486F2Q37161518-D9CDBC1F-388D-4EC6-804B-878753B8CC74Q37204267-AEADC9B5-7E92-487F-8E00-D493529F9B66Q37283027-37F1C7A2-AFC0-4526-9852-2C549AC97F23Q37335221-55123C43-43DE-4F3A-A608-936C390D35FFQ37427931-D0A7184A-7F7F-47F7-B117-62ADEFD41575Q37666711-7584D2EB-8E83-468D-BE47-5ACEE2D5EC74Q37678918-385B0427-ACFE-429B-A64C-6ED71828E93CQ37719346-C2A614D4-8B98-4E3D-BF7C-A655B685FD0DQ37731863-535CF31B-C60E-4EDD-84CA-3C0E99AF72AAQ37781110-221783CB-4515-4A6A-8252-D2EEBACE15FFQ37810340-9335BB5A-B681-414A-B690-D0FE4E42AAC4Q37960126-6267AB00-E274-4AAE-9031-446752C3CF12Q38062388-18ACE41D-E4DE-42D6-9350-56DF6F5C3B95
P2860
Population clinical pharmacology of children: modelling covariate effects.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Population clinical pharmacology of children: modelling covariate effects.
@ast
Population clinical pharmacology of children: modelling covariate effects.
@en
type
label
Population clinical pharmacology of children: modelling covariate effects.
@ast
Population clinical pharmacology of children: modelling covariate effects.
@en
prefLabel
Population clinical pharmacology of children: modelling covariate effects.
@ast
Population clinical pharmacology of children: modelling covariate effects.
@en
P2860
P1476
Population clinical pharmacology of children: modelling covariate effects
@en
P2093
Brian J Anderson
P2860
P2888
P304
P356
10.1007/S00431-006-0189-X
P577
2006-06-29T00:00:00Z